Q&A

Incorporating Automation Into Your Fill And Finish Procedure

Source: Terumo BCT
Intelligent Automation AI

In this interview, Allison Hoffman, Global Product Manager for Cell Therapy Technologies at Terumo Blood and Cell Technologies, explains how automation can be incorporated into fill and finish procedures and the impact this has on factors such as the cost of producing cell therapeutics and the quality of the final product. Allison has spent most of my career in the infusion pump and health care industries, but now supports the future of cell therapy technologies.

Disclaimer
The opinions expressed in this interview are those of the interviewee and do not necessarily reflect the views of RegMedNet or Future Science Group.

In association with Terumo Blood and Cell Technologies.

access the Q&A!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Terumo BCT